Confidence, prediction, and tolerance in linear mixed models

Stat Med. 2019 Dec 30;38(30):5603-5622. doi: 10.1002/sim.8386. Epub 2019 Oct 28.

Abstract

The literature about Prediction Interval (PI) and Tolerance Interval (TI) in linear mixed models is usually developed for specific designs, which is a main limitation to their use. This paper proposes to reformulate the two-sided PI to be generalizable under a wide variety of designs (one random factor, nested and crossed designs for multiple random factors, and balanced or unbalanced designs). This new methodology is based on the Hessian matrix, namely, the inverse of (observed) Fisher Information matrix, and is built with a cell mean model. The degrees of freedom for the total variance are calculated with the generalized Satterthwaite method and compared to the Kenward-Roger's degrees of freedom for fixed effects. Construction of two-sided TIs are also detailed with one random factor, and two nested and two crossed random variables. An extensive simulation study is carried out to compare the widths and coverage probabilities of Confidence Intervals (CI), PIs, and TIs to their nominal levels. It shows excellent coverage whatever the design and the sample size are. Finally, these CIs, PIs, and TIs are applied to two real data sets: one from orthopedic surgery study (intralesional resection risk) and the other from assay validation study during vaccine development.

Keywords: Hessian and Fisher information matrix; assay validation and qualification; generalized Satterthwaite; intralesional resection; mixed model; prediction interval; tolerance interval.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Analysis of Variance
  • Biostatistics
  • Bone Neoplasms / pathology
  • Bone Neoplasms / surgery
  • Computer Simulation
  • Confidence Intervals
  • Drug Development / statistics & numerical data
  • Humans
  • Linear Models*
  • Margins of Excision
  • Models, Statistical
  • Orthopedic Procedures / statistics & numerical data
  • Sample Size
  • Vaccines / analysis

Substances

  • Vaccines